Venture Capital News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Venture CapitalNewsGate Bioscience Raises $65M in Series B Financing
Gate Bioscience Raises $65M in Series B Financing
Venture Capital

Gate Bioscience Raises $65M in Series B Financing

•November 13, 2025
0
FinSMEs
FinSMEs•Nov 13, 2025

Companies Mentioned

Gate Bioscience

Gate Bioscience

Forbion

Forbion

FRBN

Lilly

Lilly

LLY

ARCH Venture Partners

ARCH Venture Partners

Versant Ventures

Versant Ventures

GV

GV

Why It Matters

The capital infusion validates Gate Bioscience’s novel protein‑targeting platform and accelerates its path to clinic, potentially reshaping drug discovery for inflammatory and neurological diseases. Participation by a major pharma player like Eli Lilly signals industry confidence and could spur further collaborations.

Gate Bioscience Raises $65M in Series B Financing

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...